Admetsys Unveils Novel Fully Autonomous Clinical Robotics in Hospital

Admetsys has introduced a novel automated glucose control and continuous blood diagnostics system that addresses a significant gap in the standard of care for patients.

This system is designed to manage the glucose levels and other vital blood analytes in patients, offering numerous advantages over traditional methods.

The system will automatically and continuously measure multiple blood analytes, including glucose, in real-time, all without causing any blood loss in the patient. This non-invasive approach is a major leap forward in patient comfort and safety.

The system's real innovation lies in its patient-adaptive learning algorithm. By utilising real-time biosensing data, the system creates a highly personalised computational model of each patient's metabolism.

This model evolves as the patient's condition changes, allowing for dynamic and precise optimisation of insulin and dextrose treatment using its multiple infusion channels. It offers a non-invasive, adaptive, and highly personalised approach to managing blood analytes, greatly improving patient care while maintaining economic feasibility and scalability.

This automated glucose control and continuous blood diagnostics system is a game-changer in healthcare.